GO:0036513 Derlin-1 retrotranslocation complex: Components, Assembly and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0036513 describes the Derlin-1 retrotranslocation complex, a protein complex that forms a channel for moving misfolded proteins out of the endoplasmic reticulum (ER) during ER-associated degradation (ERAD) [1,5].
• The complex is built around Derlin-1 oligomers, which assemble into a hexameric channel that provides a passage for substrates [1,5].
• Key substrates include CFTR and its folding mutants, ENaC, ATP-sensitive potassium channels, and cyclooxygenase-2, which are retrotranslocated for proteasomal degradation [2,4,6,7].
• The complex interacts with the AAA-ATPase p97 (VCP) and other cofactors such as BAP31 to facilitate substrate extraction [1,3].
• Dysfunction of Derlin-1 retrotranslocation is linked to diseases such as cystic fibrosis and cancer, making it a target for therapeutic research [3,6].
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) enable precise dissection of Derlin-1 complex function in health and disease [1,4].
Description
The Derlin-1 retrotranslocation complex (GO:0036513) is a cellular component that functions in the retrotranslocation step of ER-associated protein degradation (ERAD), a quality-control pathway that removes misfolded or unwanted proteins from the endoplasmic reticulum (ER) [1,5]. At its core, Derlin-1 oligomers form a retrotranslocation channel that allows substrates to be moved from the ER lumen or membrane into the cytosol for proteasomal degradation [1,5]. This complex is essential for maintaining ER proteostasis and is conserved from yeast to humans [1,5]. Researchers study GO:0036513 to understand how cells handle protein misfolding, how pathogens exploit ERAD, and how defects in this process contribute to diseases such as cystic fibrosis and cancer [3,6]. The complex is also a hub for interactions with the AAA-ATPase p97 (VCP) and other cofactors that provide the driving force for substrate extraction [1,3]. Understanding the structure and regulation of the Derlin-1 retrotranslocation complex is therefore critical for both basic cell biology and therapeutic development [1,5].
Derlin-1 retrotranslocation complex At A Glance
| GO ID | GO:0036513 |
|---|---|
| GO term | Derlin-1 retrotranslocation complex |
| Ontology | cellular_component |
| Synonym | Derlin-1 complex; Derlin-1 protein dislocation complex; Derlin-1 retro-translocation complex; Derlin-1 retrotranslocon; ERAD protein dislocation complex |
| Major function | Retrotranslocation of ERAD substrates from the ER to the cytosol for proteasomal degradation |
| Core component | Derlin-1 oligomers forming a hexameric channel |
| Key interactors | p97 (VCP), BAP31, and other ERAD factors |
| Subcellular location | Endoplasmic reticulum membrane |
| Associated process | ER-associated protein degradation (ERAD) |
What Is GO:0036513?
The Derlin-1 retrotranslocation complex is a protein complex that functions in the retrotranslocation step of ERAD, and includes at its core Derlin-1 oligomers forming a retrotranslocation channel [1,5]. It is also known as the Derlin-1 complex, Derlin-1 protein dislocation complex, Derlin-1 retro-translocation complex, Derlin-1 retrotranslocon, or ERAD protein dislocation complex [1,5].
Why Is Derlin-1 retrotranslocation complex Important in Cell Biology?
The Derlin-1 retrotranslocation complex is a central component of ERAD, a pathway that protects cells from the toxic accumulation of misfolded proteins [1,5]. Its dysfunction has been implicated in a range of human diseases, including cystic fibrosis, where it mediates the degradation of the CFTR folding mutant CFTRDeltaF508 [3,6], and cancer, where it regulates the stability of proteins such as cyclooxygenase-2. Understanding this complex provides insights into basic ER biology and offers potential targets for therapeutic intervention [1,5].
• Maintains ER proteostasis by clearing misfolded proteins [1,5].
• Mediates the degradation of CFTR and its disease-causing mutant CFTRDeltaF508 [3,6].
• Regulates the stability of ion channels such as ENaC and ATP-sensitive potassium channels [4,7].
• Interacts with p97 (VCP) to provide the mechanical force for substrate extraction.
• Involved in the degradation of cyclooxygenase-2, linking it to inflammation and cancer.
• Can be exploited by viruses, as shown for Mouse Mammary Tumor Virus signal peptide, which uses a Derlin-independent retrotranslocation mechanism.
• Serves as a model for studying protein quality control and ERAD [1,5].
• Potential therapeutic target for diseases caused by protein misfolding [3,6].
Derlin-1 retrotranslocation complex: mechanism, structure, and regulation
Substrate recognition and targeting
In simple terms: The complex first identifies which proteins need to be destroyed.
Misfolded or regulated proteins in the ER are recognized by ERAD machinery, often through chaperones and lectins that detect exposed hydrophobic patches or specific degradation signals [1,5]. The Derlin-1 retrotranslocation complex is then recruited to these substrates, positioning them for retrotranslocation [1,5].
Retrotranslocation through the Derlin-1 channel
In simple terms: The misfolded protein is pushed out of the ER through a tunnel made of Derlin-1 proteins.
Derlin-1 oligomers form a hexameric channel that serves as the conduit for substrates to move from the ER membrane or lumen into the cytosol [1,5]. This step is energy-dependent and requires the AAA-ATPase p97 (VCP), which binds to the complex and extracts substrates through the channel.
Ubiquitination and proteasomal degradation
In simple terms: Once outside the ER, the protein is tagged and destroyed by the proteasome.
Substrates are ubiquitinated by ERAD-associated E3 ligases before or during retrotranslocation, and the ubiquitin chains are recognized by p97 and its cofactors [1,5]. The extracted proteins are then delivered to the proteasome for degradation [1,5].
Structural organization of the Derlin-1 complex
In simple terms: The complex is built from multiple Derlin-1 proteins that assemble into a ring-like structure.
Cryo-EM studies have revealed that human Derlin-1 forms a hexameric channel, with each subunit contributing to the central pore [1,5]. The complex associates with p97 and other cofactors, forming a larger retrotranslocation machinery [1,5].
Regulation and cofactors
In simple terms: Other proteins help control when and how the complex works.
The Derlin-1 complex is regulated by interactions with proteins such as BAP31, which promotes retrotranslocation of CFTRDeltaF508, and caveolin-1, which collaborates with p97 for cyclooxygenase-2 degradation. Additionally, some substrates, like the Mouse Mammary Tumor Virus signal peptide, can use a Derlin-independent retrotranslocation mechanism, highlighting alternative pathways.
Key Genes Involved in GO:0036513 Derlin-1 retrotranslocation complex
The following genes and proteins are key components or interactors of the Derlin-1 retrotranslocation complex.
| Gene | Major Role | Research Relevance |
|---|---|---|
| DERL1 | Core channel-forming subunit of the retrotranslocation complex | Essential for ERAD; knockout leads to ER stress and substrate accumulation [1,5] |
| VCP (p97) | AAA-ATPase that provides force for substrate extraction | Mutations cause IBMPFD and ALS; target for cancer therapy |
| BAP31 | ER membrane protein that interacts with Sec61 and Derlin-1 | Promotes retrotranslocation of CFTRDeltaF508 |
| CFTR | Chloride channel; misfolded mutants are ERAD substrates | CFTRDeltaF508 degradation depends on Derlin-1 [3,6] |
| ENaC | Epithelial sodium channel; regulated by Derlin-1-mediated degradation | Derlin-1 promotes ubiquitination and degradation of ENaC |
| KATP channels | ATP-sensitive potassium channels; regulated by Derlin-1 | Derlin-1 influences proteostasis of KATP channels |
| COX-2 (PTGS2) | Cyclooxygenase-2; degraded via Derlin-1 and p97 | Caveolin-1 links Derlin-1 to COX-2 degradation |
| CAV1 | Caveolin-1; interacts with Derlin-1 | Promotes ubiquitination and degradation of COX-2 |
| SEC61 | ER translocon; interacts with BAP31 and Derlin-1 | Involved in retrotranslocation of CFTRDeltaF508 |
| UBB | Ubiquitin; tags substrates for degradation | Essential for ERAD substrate modification [1,5] |
| UBC | Ubiquitin-conjugating enzymes | Participate in ubiquitination of ERAD substrates [1,5] |
| NPLOC4 | p97 cofactor; involved in ERAD | Assists in substrate extraction |
| UFD1L | p97 cofactor; involved in ERAD | Assists in substrate extraction |
| HERPUD1 | ER membrane protein; involved in ERAD | May regulate Derlin-1 complex assembly [1,5] |
| SEL1L | ERAD component; part of Hrd1 complex | Cooperates with Derlin-1 in retrotranslocation [1,5] |
| SYVN1 (HRD1) | E3 ubiquitin ligase in ERAD | Ubiquitinates substrates for Derlin-1-mediated retrotranslocation [1,5] |
| AMFR (GP78) | E3 ubiquitin ligase in ERAD | Ubiquitinates substrates for retrotranslocation [1,5] |
| RNF5 | E3 ubiquitin ligase | Regulates ERAD of specific substrates [1,5] |
How Is Derlin-1 retrotranslocation complex Regulated?
The Derlin-1 retrotranslocation complex is regulated at multiple levels. Its activity depends on the AAA-ATPase p97 (VCP), which binds to the complex and hydrolyzes ATP to extract substrates. Co-factors such as BAP31 and caveolin-1 modulate substrate specificity and efficiency [2,3]. Additionally, the complex can be bypassed by certain substrates, as seen with the Mouse Mammary Tumor Virus signal peptide, which uses a Derlin-independent retrotranslocation mechanism. Transcriptional regulation of DERL1 and other ERAD genes occurs under ER stress via the unfolded protein response, though specific details require further study [1,5].
Derlin-1 retrotranslocation complex and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CFTR | Cystic fibrosis | Knockout of DERL1 in CFBE41o- cells to assess CFTRDeltaF508 rescue [3,6] |
| PTGS2 (COX-2) | Cancer, inflammation | Overexpression of CAV1 and DERL1 in HEK293 cells to study COX-2 degradation |
| ENaC | Hypertension, Liddle syndrome | Knockdown of DERL1 in renal epithelial cells to measure ENaC stability |
| KATP channels | Neonatal diabetes, hyperinsulinism | Derlin-1 knockout in pancreatic beta cells to assess KATP channel proteostasis |
| VCP (p97) | IBMPFD, ALS | Knock-in of disease-associated VCP mutations in motor neurons |
Cystic Fibrosis
The most common cystic fibrosis mutation, CFTRDeltaF508, causes the protein to misfold and be degraded by ERAD [3,6]. Derlin-1 promotes the efficient degradation of CFTR and its folding mutants, and BAP31 interacts with the Derlin-1 complex to enhance retrotranslocation of CFTRDeltaF508 [3,6]. Inhibiting this pathway could potentially rescue mutant CFTR function.
Cancer
Derlin-1 is overexpressed in several cancers and contributes to tumor progression by regulating the stability of proteins such as cyclooxygenase-2 (COX-2). Caveolin-1 interacts with Derlin-1 to promote ubiquitination and degradation of COX-2 via the p97 complex, linking ERAD to inflammation and cancer.
Protein Misfolding Disorders
Dysfunction of ERAD, including the Derlin-1 retrotranslocation complex, is implicated in neurodegenerative diseases and other protein misfolding disorders, although specific mechanisms remain to be fully elucidated [1,5].
From Derlin-1 retrotranslocation complex-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does Derlin-1 knockout impair ERAD of CFTRDeltaF508? | DERL1 knockout in CFBE41o- or HeLa cells [3,6] |
| How does a point mutation in DERL1 affect channel assembly? | Point mutation knock-in of DERL1 in HEK293 cells |
| Can tagged Derlin-1 be used to isolate the complex? | Knock-in of FLAG- or GFP-tagged DERL1 [1,5] |
| Does overexpression of Derlin-1 enhance degradation of a substrate? | Overexpression of DERL1 in COS-7 or HEK293 cells [2,4] |
| What is the effect of Derlin-1 knockout on KATP channel surface expression? | DERL1 knockout in INS-1 or MIN6 cells |
| Can CRISPR screening identify novel regulators of Derlin-1 complex? | Genome-wide CRISPR knockout library in ERAD reporter cells [1,5] |
How to Study the Derlin-1 retrotranslocation complex Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Cryo-EM | 3D structure of the complex | Determining channel architecture [1,5] |
| Co-immunoprecipitation | Protein-protein interactions | Identifying p97, BAP31, caveolin-1 interactions [1,2,3] |
| Cycloheximide chase | Degradation kinetics of substrates | Assessing CFTRDeltaF508 or ENaC stability [3,4,6] |
| Ubiquitination assays | Substrate ubiquitination | Measuring Derlin-1-dependent ubiquitination |
| CRISPR knockout | Gene function | Creating DERL1 knockout cells [1,5] |
| Overexpression | Gain-of-function effects | Enhancing substrate degradation [2,4] |
| RNA-seq | Transcriptional changes | Measuring ER stress response [1,5] |
| Proteomics | Global protein changes | Identifying ERAD substrates [1,5] |
Structural Biology (Cryo-EM)
Cryo-electron microscopy has been used to determine the structure of the human Derlin-1/p97 complex, revealing a hexameric channel [1,5]. This method provides high-resolution insights into the architecture of the retrotranslocation machinery.
Proteomics and Interactomics
Affinity purification coupled with mass spectrometry can identify proteins that interact with the Derlin-1 complex, such as p97, BAP31, and caveolin-1 [1,2,3]. This helps define the composition and dynamics of the complex.
Functional Assays for ERAD
Cycloheximide chase assays and pulse-chase experiments monitor the degradation of substrates like CFTRDeltaF508 or ENaC in the presence or absence of Derlin-1 [3,4,6]. These assays are essential for quantifying retrotranslocation efficiency.
CRISPR Screening
Genome-wide CRISPR knockout screens can identify genes that regulate Derlin-1 complex function or compensate for its loss [1,5]. This approach is powerful for discovering novel ERAD components.
How CRISPR Can Be Used to Study GO:0036513 Derlin-1 retrotranslocation complex
Knockout
CRISPR knockout of DERL1 or other complex components can abolish retrotranslocation, leading to substrate accumulation and ER stress [1,5]. This is useful for studying the essentiality of the complex in ERAD.
Point Mutation
Introducing point mutations in DERL1 can dissect the functional domains required for channel formation or p97 interaction. Such models help link specific residues to retrotranslocation activity.
Knock-in
Knock-in of tagged DERL1 (e.g., FLAG, GFP) allows for affinity purification and imaging of the complex in live cells [1,5]. This enables real-time tracking of complex assembly and localization.
Overexpression
Overexpression of DERL1 or its cofactors can enhance ERAD of specific substrates, providing a gain-of-function system to study substrate degradation [2,4]. This is particularly useful for testing therapeutic strategies.
How EDITGENE Supports Derlin-1 retrotranslocation complex Research
Researchers studying Derlin-1 retrotranslocation complex-related genes often need to determine whether a candidate gene is causally involved in ERAD, how mutations affect complex assembly, and whether modulating its activity can rescue disease phenotypes. EDITGENE provides tailored CRISPR solutions to address these questions with precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for Derlin-1 retrotranslocation complex research.
Frequently Asked Questions About Derlin-1 retrotranslocation complex
What is the Derlin-1 retrotranslocation complex?
It is a protein complex (GO:0036513) that forms a channel for moving misfolded proteins out of the ER during ERAD [1,5].
What genes are involved in the Derlin-1 retrotranslocation complex?
Key genes include DERL1, VCP (p97), BAP31, CFTR, ENaC, and COX-2, among others [1,2,3,4,6].
What is the function of Derlin-1 in ERAD?
Derlin-1 oligomerizes to form a retrotranslocation channel that allows ERAD substrates to be extracted from the ER for proteasomal degradation [1,5].
How is the Derlin-1 complex structured?
Cryo-EM studies show that human Derlin-1 forms a hexameric channel, which associates with p97 and other cofactors [1,5].
What diseases are associated with Derlin-1 dysfunction?
Cystic fibrosis, cancer, and protein misfolding disorders have been linked to defects in Derlin-1-mediated ERAD [2,3,6].
How can I study the Derlin-1 retrotranslocation complex?
Use CRISPR knockout, point mutation, knock-in, or overexpression models, combined with cryo-EM, proteomics, and functional degradation assays [1,3,4].
What are the substrates of the Derlin-1 complex?
Substrates include CFTRDeltaF508, ENaC, ATP-sensitive potassium channels, and cyclooxygenase-2 [2,4,6,7].
Does Derlin-1 interact with p97?
Yes, p97 (VCP) binds to the Derlin-1 complex and provides the ATP-driven force for substrate extraction.
Can viruses exploit the Derlin-1 complex?
Some viruses, like Mouse Mammary Tumor Virus, use a Derlin-independent retrotranslocation mechanism to escape proteasomal degradation.
What CRISPR services does EDITGENE offer for ERAD research?
EDITGENE provides knockout, point mutation, knock-in, overexpression, library screening, and bioinformatics services for genes like DERL1 and VCP [1,5].
Conclusion
The Derlin-1 retrotranslocation complex (GO:0036513) is a critical component of ERAD, responsible for extracting misfolded proteins from the ER for degradation [1,5]. Its structure, regulation, and interactions with p97 and other cofactors have been illuminated by recent cryo-EM and functional studies [1,3,5]. Dysregulation of this complex contributes to diseases such as cystic fibrosis and cancer, making it an attractive target for therapeutic intervention [2,3,6]. Continued research using advanced CRISPR models and structural biology will further unravel its mechanisms and potential for clinical translation [1,5].
References
- 1. Wang Q et al.. 2025. Cryo-EM structure of the human Derlin-1/p97 complex reveals a hexameric channel in ERAD.. Commun Biol 8(1):1481 PMID: 41107410
- 2. Chen SF et al.. 2013. Caveolin-1 interacts with Derlin-1 and promotes ubiquitination and degradation of cyclooxygenase-2 via collaboration with p97 complex.. J Biol Chem 288(46):33462-9 PMID: 24089527
- 3. Wang B et al.. 2008. BAP31 interacts with Sec61 translocons and promotes retrotranslocation of CFTRDeltaF508 via the derlin-1 complex.. Cell 133(6):1080-92 PMID: 18555783
- 4. You H et al.. 2017. Derlin-1 promotes ubiquitylation and degradation of the epithelial Na(+) channel, ENaC.. J Cell Sci 130(6):1027-1036 PMID: 28137758
- 5. Rao B et al.. 2023. The cryo-EM structure of the human ERAD retrotranslocation complex.. Sci Adv 9(41):eadi5656 PMID: 37831771
- 6. Sun F et al.. 2006. Derlin-1 promotes the efficient degradation of the cystic fibrosis transmembrane conductance regulator (CFTR) and CFTR folding mutants.. J Biol Chem 281(48):36856-63 PMID: 16954204
- 7. Wang F et al.. 2012. Role of Derlin-1 protein in proteostasis regulation of ATP-sensitive potassium channels.. J Biol Chem 287(13):10482-10493 PMID: 22311976
- 8. Byun H et al.. 2017. Mouse Mammary Tumor Virus Signal Peptide Uses a Novel p97-Dependent and Derlin-Independent Retrotranslocation Mechanism To Escape Proteasomal Degradation.. mBio 8(2) PMID: 28351922
